Review



primary antibody panck  (Biocare Medical)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Biocare Medical primary antibody panck
    Primary Antibody Panck, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody panck/product/Biocare Medical
    Average 90 stars, based on 1 article reviews
    primary antibody panck - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    anti-panck (ae1/ae3) mouse monoclonal primary antibody  (Novus Biologicals)
    90
    Novus Biologicals anti-panck (ae1/ae3) mouse monoclonal primary antibody
    Anti Panck (Ae1/Ae3) Mouse Monoclonal Primary Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-panck (ae1/ae3) mouse monoclonal primary antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    anti-panck (ae1/ae3) mouse monoclonal primary antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibodies panck  (OriGene)
    90
    OriGene primary antibodies panck
    Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of <t>CD8</t> cells during the progression process. (E) Monocle pseudotime trajectory analysis of <t>CD4</t> cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, <t>FOXP3,</t> and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.
    Primary Antibodies Panck, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies panck/product/OriGene
    Average 90 stars, based on 1 article reviews
    primary antibodies panck - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibodies against panck  (Servicebio Inc)
    90
    Servicebio Inc primary antibodies against panck
    Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of <t>CD8</t> cells during the progression process. (E) Monocle pseudotime trajectory analysis of <t>CD4</t> cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, <t>FOXP3,</t> and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.
    Primary Antibodies Against Panck, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against panck/product/Servicebio Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against panck - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibodies to ck18, panck, e-cadherin, and β-catenin  (Servicebio Inc)
    90
    Servicebio Inc primary antibodies to ck18, panck, e-cadherin, and β-catenin
    Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of <t>CD8</t> cells during the progression process. (E) Monocle pseudotime trajectory analysis of <t>CD4</t> cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, <t>FOXP3,</t> and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.
    Primary Antibodies To Ck18, Panck, E Cadherin, And β Catenin, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies to ck18, panck, e-cadherin, and β-catenin/product/Servicebio Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies to ck18, panck, e-cadherin, and β-catenin - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibodies against panck  (Proteintech)
    95
    Proteintech primary antibodies against panck
    Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of <t>CD8</t> cells during the progression process. (E) Monocle pseudotime trajectory analysis of <t>CD4</t> cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, <t>FOXP3,</t> and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.
    Primary Antibodies Against Panck, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against panck/product/Proteintech
    Average 95 stars, based on 1 article reviews
    primary antibodies against panck - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    primary antibodies against panck  (ZSGB Biotech)
    90
    ZSGB Biotech primary antibodies against panck
    Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of <t>CD8</t> cells during the progression process. (E) Monocle pseudotime trajectory analysis of <t>CD4</t> cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, <t>FOXP3,</t> and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.
    Primary Antibodies Against Panck, supplied by ZSGB Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against panck/product/ZSGB Biotech
    Average 90 stars, based on 1 article reviews
    primary antibodies against panck - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibody panck  (Biocare Medical)
    90
    Biocare Medical primary antibody panck
    Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of <t>CD8</t> cells during the progression process. (E) Monocle pseudotime trajectory analysis of <t>CD4</t> cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, <t>FOXP3,</t> and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.
    Primary Antibody Panck, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody panck/product/Biocare Medical
    Average 90 stars, based on 1 article reviews
    primary antibody panck - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibody panck clone ae1/ae3  (Thermo Fisher)
    90
    Thermo Fisher primary antibody panck clone ae1/ae3
    Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of <t>CD8</t> cells during the progression process. (E) Monocle pseudotime trajectory analysis of <t>CD4</t> cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, <t>FOXP3,</t> and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.
    Primary Antibody Panck Clone Ae1/Ae3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody panck clone ae1/ae3/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    primary antibody panck clone ae1/ae3 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of CD8 cells during the progression process. (E) Monocle pseudotime trajectory analysis of CD4 cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, FOXP3, and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.

    Journal: Theranostics

    Article Title: Single-nucleus RNA sequencing and spatial transcriptomics reveal an immunosuppressive tumor microenvironment related to metastatic dissemination during pancreatic cancer liver metastasis

    doi: 10.7150/thno.108925

    Figure Lengend Snippet: Transcriptional signatures of lymphoid cells identified by snRNA-seq. (A) UMAP plot of the lymphoid cell landscape, coloured by subcluster. (B) Feature plots showing the normalized expression of specific marker genes in lymphoid cells. (C) Heatmap showing the average expression levels of selected genes across 11 lymphoid subclusters. (D) Monocle pseudotime trajectory analysis of CD8 cells during the progression process. (E) Monocle pseudotime trajectory analysis of CD4 cells during the progression process. (F) Immunofluorescence assay for PanCK, CD4, FOXP3, and DAPI in PT and LM samples. Scale bars, 50 µm. (G) Statistical analysis of the number of CD4 FOXP3 T cells in PT and LM, statistical testing was performed using the t-test (**, p < 0.01). (H) Heatmap of immune checkpoint genes in lymphoid cells, with annotations of receptor or ligand, inhibitory or stimulatory roles. The bars at the top indicate receptor or ligand type, while the left bars indicate sample source and lymphoid cell type annotations. (I) KEGG pathway enrichment analysis of differentially expressed genes between CD4 FOXP3 T cells from PT and LM, with a significance threshold of p < 0.05 and log 2 (fold change) ≥ 0.5. (J) Box plots showing TIL (tumor-infiltrating lymphocytes), cytotoxic, and Treg scores for lymphoid cells in PT and LM, statistical testing performed using the t-test (****, p < 0.0001). (K) Bar plots showing the proportions of 11 lymphoid subclusters in PT and LM.

    Article Snippet: The sections were incubated with primary antibodies (CD4, CD8, FOXP3, CD20, panCK, and VIM from ZSbio or CST) for 30 min at room temperature, followed by a 10 min incubation with PVB tyramide signal amplification fluorophore (PVB 480, PVB 520, PVB 50, PVB 620, PVB 690, and PVB 780).

    Techniques: Expressing, Marker, Immunofluorescence